PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Li,Wu

第一单位： Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

作者： Li,Wu ^[1] ; Bo,Zhang ^[2] ; Chenghao,Li ^[3] ; Zhuolin,Zhuang ^[3] ; Kang,Liu ^[1] ; Hualin,Chen ^[1] ; Shuanggen,Zhu ^[4] ; Juehua,Zhu ^[5] ; Zheng,Dai ^[6] ; Huameng,Huang ^[7] ; Yongjun,Jiang ^[8]

作者单位： Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. ^[1] Department of Neurology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. ^[2] Department of Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. ^[3] Department of Neurology, Shenzhen Longhua District Central Hospital, The Affiliated Hospital of Guangdong Medical University, Shenzhen, Guangdong, China. ^[4] Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. ^[5] Department of Neurology, Wuxi People's Hospital, Wuxi, Jiangsu, China. ^[6] Department of Neurology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China jiangyjnju@gmail.com 15219078888@139.com. ^[7] Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China jiangyjnju@gmail.com 15219078888@139.com. ^[8]

关键词 PCSK9 inhibitors atherosclerosis early recurrent stroke intracranial atherosclerotic stenosis stroke